XOMA Royalty (XOMA) Return on Capital Employed (2011 - 2026)

XOMA Royalty's (XOMA) quarterly Return on Capital Employed came in at 0.11% in Q1 2026, up 1387.0% year-on-year from 0.01% in Q1 2025, and down 96.03% quarter-over-quarter from 2.87% in Q4 2025.

XOMA Royalty (XOMA) Return on Capital Employed (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed Return on Capital Employed across 16 years of filings, most recently posting 0.11% for Q1 2026.

  • Return on Capital Employed for Q1 2026 came in at 0.11%, up 1387.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.11% (up 1387.0% YoY), and the FY2025 annual result was 3.15%, up 2280.0% from the prior year.
  • Return on Capital Employed came in at 0.11% for Q1 2026 at XOMA Royalty, down from 2.87% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 14.13% in Q1 2022 to a low of 26.2% in Q4 2023.
  • The 5-year median for Return on Capital Employed is 13.76% (2025), against an average of 9.65%.
  • Across the five-year window, Return on Capital Employed plunged 3779 bps in 2023 and soared 2572 bps in 2025, its largest moves.
  • XOMA Royalty's Return on Capital Employed stood at 12.76% in 2022, then tumbled by 105 bps to 26.2% in 2023, then rose by 23 bps to 20.2% in 2024, then soared by 114 bps to 2.87% in 2025, then tumbled by 96 bps to 0.11% in 2026.
  • The last three Return on Capital Employed figures came in at 0.11% (Q1 2026), 2.87% (Q4 2025), and 0.91% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 450.31%
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 51.73%
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -107.40%
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 21.10%
9 Abivax 95.45 Bn 95.45 Bn - -50.43%
10 XOMA Royalty 5.52 Mn -60.56 Mn - 0.11%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.11%
Dec 31, 2025 2.87%
Sep 30, 2025 0.91%
Jun 30, 2025 -6.29%
Mar 31, 2025 -13.76%
Dec 31, 2024 -20.20%
Sep 30, 2024 -24.82%
Jun 30, 2024 -20.12%
Mar 31, 2024 -18.30%
Dec 31, 2023 -26.20%
Sep 30, 2023 -24.55%
Jun 30, 2023 -21.79%
Mar 31, 2023 -20.10%
Dec 31, 2022 -12.76%
Sep 30, 2022 13.24%
Jun 30, 2022 13.62%
Mar 31, 2022 14.13%
Dec 31, 2021 12.93%
Sep 30, 2021 8.72%
Jun 30, 2021 9.62%